コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 mpaired permeability to 100=complete loss of barrier function).
2 tural integrity of the cuticle, and impaired barrier function.
3 pithelial cell count, metabolic activity, or barrier function.
4 that regulates angiogenesis and endothelial barrier function.
5 eins to disrupt the epithelial integrity and barrier function.
6 r 1 (PAR1)-induced impairment of endothelial barrier function.
7 dult CNS homeostasis but does not affect BBB barrier function.
8 ction (SSJ) which is required for intestinal barrier function.
9 ented deleterious effects of cytokines on EC barrier function.
10 of EI was detected, reflecting the decreased barrier function.
11 lular matrix stiffness regulates endothelial barrier function.
12 indicating a local regulation of endothelial barrier function.
13 in IECs and thereby epithelial integrity and barrier function.
14 ze short-lived, local breaches in epithelial barrier function.
15 eukostasis, and restoration of retinal blood-barrier function.
16 tzia consistently positively covary with IML barrier function.
17 nized as essential regulators of endothelial barrier function.
18 s exit from a quiescent state and compromise barrier function.
19 ed an investigation of intestinal epithelial barrier function.
20 They also secrete IL22 to promote barrier function.
21 rylated (p-Y280) in association with loss of barrier function.
22 r, which suggests a protective intracellular barrier function.
23 em63c in mediating the glomerular filtration barrier function.
24 malized both VE-cadherin organization and EC barrier function.
25 ling and reestablish the critical epithelial barrier function.
26 ls leading to the loss of colonic epithelial barrier function.
27 sence is linked to an impairment in the skin barrier function.
28 fied FBXW7 as a key regulator of endothelial barrier function.
29 no acid tryptophan, in regulating intestinal barrier function.
30 uclear pore channel, affecting its selective barrier function.
31 he role of the microbiota in determining IML barrier function.
32 icating that Fn14 is crucial for endothelial barrier function.
33 dothelial junctions and promotes endothelial barrier function.
34 mber has been used for many years to measure barrier function.
35 ping the integrity of gastric mucosa and its barrier function.
36 lammation, M2 macrophage activation and skin barrier function.
37 with clinical changes in lesion severity and barrier function.
38 d both glomerular protection and endothelial barrier function.
39 te detrusor contractility and the urothelial barrier function.
40 adherens junction integrity and endothelial barrier function.
41 vessels and edema by regulating endothelial barrier function.
42 itions characterized by compromised vascular barrier function.
43 chain kinase-induced increases in epithelial barrier function.
44 resulted in perturbed glomerular filtration barrier function.
45 d functional wound closure by restoring skin barrier function.
46 elial program activation, and acquisition of barrier function.
47 E-cadherin is critically required for skin barrier function.
48 r cells are critical to maintain respiratory barrier function.
49 nctions for Podxl in maintaining endothelial barrier function.
50 ce was measured to determine epithelial cell barrier function.
51 othelial morphology and impaired endothelial barrier function.
52 y which matrix stiffening alters endothelial barrier function.
53 to bowel wall oedema and impaired intestinal barrier function.
54 ct of PlGF on G6PD protein expression and EC barrier function.
55 microbiota ensures maintenance of intestinal barrier function.
56 which may in turn alter the protective skin barrier function.
57 ght junction formation and hence improve the barrier function.
58 e in IBD development by enhancing intestinal barrier function.
59 tribute to the inner vs. outer blood-retinal barrier function.
60 ownstream of JAM-A, to thus enhance vascular barrier function.
61 of oxidative stress, and altered intestinal barrier function.
62 icrobiome, and the decrease in the epidermal barrier function.
63 , microbial colonization, and the epithelial barrier function.
64 IECs and macrophages to maintain intestinal barrier function.
65 AEC to the epithelium is necessary to impair barrier function.
66 he primary outcomes were risk of AE and skin barrier function.
67 y specifically targeting impaired intestinal barrier function.
68 ch has previously been shown to improve skin barrier function.
69 massive vascular retraction without loss of barrier function.
70 pression of genes that are known to regulate barrier function.
71 pression in IGF2BP1-knockdown cells restored barrier function.
72 oride protected against CDCA-induced loss of barrier function.
73 ic further impairment of endothelial and gut barrier function.
74 elial IL-10(+) lymphocytes regulating the SI barrier function.
75 ontinuous stress linked to its digestive and barrier functions.
76 to isolate damaged neural tissue and restore barrier functions.
77 of BCRP-mediated intestinal drug efflux and barrier functions.
78 ivalis (Pg)-induced impairment of epithelial barrier functions.
79 sion and compromised colonic drug efflux and barrier functions.
80 nmental insults in humans with impaired skin barrier functions.
81 bile duct in three dimensions, but also its barrier functions.
83 for detecting changes in platelet-dependent barrier function, 3) identify which platelet processes a
84 it to the host, boosting multiple aspects of barrier function, a critical function of this essential
85 ssociated with a local change in endothelial barrier function, a direct proof is missing mainly becau
86 -PCR, transepithelial electrical resistance, barrier function, actin localization, wound healing, mit
87 ication, impaired S1pr2(-/-) mouse epidermal barrier function allowed deeper bacterial penetration an
89 ns with a role in maintenance of endothelial barrier function, although how this is accomplished rema
90 n endothelial cell lines results in impaired barrier function and a synthetic repertoire suggestive o
93 ons and included genes regulating epithelial barrier function and defense mechanisms, such as IL1B, I
94 derived glomeruli can develop an appropriate barrier function and discriminate between molecules of v
96 he colon associated with impaired intestinal barrier function and epithelial glycocalyx disruption.
101 cytokines impact antimicrobial function and barrier function and how T cell cytokines influence the
102 s that modulate SI microbiome, immunity, and barrier function and identify dietary, epithelial, and i
103 ne variants compromise intestinal epithelial barrier function and increase the risk of inflammatory d
104 usion, S1pr2(-/-) mice have compromised skin barrier function and increased bacteria permeability, ma
105 e demonstrated that CCHF impaired intestinal barrier function and increased translocation of endotoxi
108 c analogue (UAS03) significantly enhance gut barrier function and inhibit unwarranted inflammation.
109 ficult to conduct mechanistic studies on the barrier function and interactions with drugs at molecula
111 characterized pathological tissue integrity, barrier function and metabolic stability over time.
113 (SagA) were sufficient to enhance intestinal barrier function and pathogen tolerance, but the precise
115 DRA in maintaining the intestinal epithelial barrier function and potential implications of its dysre
117 Skin wound repair is essential to restore barrier function and prevent infection after tissue dama
119 rate, lactate, and polysaccharide A improved barrier function and reduced gliadin-induced cytokine se
122 O-GlcNAcylation in altering the endothelial barrier function and reveal a potential therapeutic targ
123 ighlights the need to better understand both barrier function and S. aureus colonization in LE, two n
124 de of CXCL5 or neutrophil depletion restored barrier function and SC differentiation after epidermal
125 e printed constructs demonstrate endothelium barrier function and spontaneous beating of cardiac musc
126 potential regulator of esophageal epithelial barrier function and suggest that downstream chromatin m
127 ia gradient in the chip increased intestinal barrier function and sustained a physiologically relevan
128 ependent on a remarkable capacity to restore barrier function and tissue homeostasis after injury.
129 Loss of KRIT1 leads to decreased microvessel barrier function and to the development of the vascular
130 ects, including those involved in epithelial barrier function and type 2-associated inflammatory resp
133 of BCRP-mediated intestinal drug efflux and barrier functions and establish a role for BCRP in preve
135 ronment, thereby supporting homeostatic skin barrier functions and providing defense against pathogen
136 al activities at gut epithelium by enhancing barrier functions and reducing inflammation to protect f
137 and beta-catenin complex and promoting their barrier function, and (iii) chemotaxis by modulating the
138 termine their associations with AD severity, barrier function, and epidermal gene expression in the f
139 protease, anti-microbial defense, epithelial barrier function, and epigenetic modification were obser
141 critical for nutrient absorption, intestinal barrier function, and innate and adaptive immune respons
142 receptor signaling, cytokine signaling, skin barrier function, and mast cell function, as well as pat
143 vascular sprouting and branching, decreased barrier function, and poor perfusion accompanied by loos
148 ependent claudin-1 expression and epithelial barrier function, as documented in 3D organotypic epithe
149 lation of actomyosin-based contractility and barrier function at tight junctions as well as E-cadheri
150 eir interactions are crucial for maintaining barrier functions at tissues constantly exposed to the e
151 nvolves genes that reflect the importance of barrier function biology, and to HLA region genes, which
152 nalling is dispensable for blood endothelial barrier function, but required for stabilization of lymp
154 hod to directly assess in vivo the epidermal barrier function by electrical impedance (EI) spectrosco
155 cells with Porphyromonas gingivalis disrupts barrier function by inducing epigenetic alterations and
156 nformation about how FATP4 can contribute to barrier function by regulating fatty acyl moieties in va
157 Tight junctions contribute to epithelial barrier function by selectively regulating the quantity
159 isease associated with broad defects in skin barrier function caused by increased levels of type-2 cy
160 on of BBB markers and maintain physiological barrier function comparable to non-cryopreserved cells.
161 skin has no difference in its phenotype and barrier function compared with that of wild-type mouse,
163 ues associated with BBB models: cell source, barrier function, cryopreservation, and matrix stiffness
164 barrier integrity revealed that VEGF induces barrier function disruption, but recombinant human GREM1
165 y and its role in maintaining the intestinal barrier function during CLGI-associated obesity are unkn
167 atory skin disease characterized by impaired barrier function, eczematous dermatitis, and chronic pru
169 more by dysregulated allergy and epithelial barrier function genes, whereas the cause of adult-onset
170 overgrowth/dysbiosis and altered intestinal barrier function (gut-liver axis) and by episodes of sep
171 ILC-related mechanisms underlying intestinal barrier function, homeostatic regulation, and graft reje
172 oved individually with only minor effects on barrier function; however, depletion of either BamA or B
173 othelial cell (EC)-derived signals reduce PC barrier function; however, the signaling mechanisms are
174 kb1 in adult mice led to impaired intestinal barrier function, hypoglycemia, and abnormal serum metab
176 epithelium are compromised by reductions in barrier function, impaired host defense to pathogens, an
177 audin-18 was sufficient to impair epithelial barrier function in 16HBE cells and in mouse airways.
178 , and esophageal epithelial architecture and barrier function in a primary human esophageal keratinoc
180 assay while also enabling the measurement of barrier function in an organ-on-a-chip incorporating 3D
182 is responsible for controlling transport and barrier function in biological systems, and its properti
184 vitro that physiologic levels of OSM impair barrier function in differentiated airway epithelium.
187 or pharmacological HDAC6 inhibition rescued barrier function in HKSA-challenged vascular endothelium
188 jor role for TRPV4 in Ca(2+) homeostasis and barrier function in human retinal capillaries and sugges
189 s of the F-box protein family on endothelial barrier function in human umbilical vein endothelial cel
191 of lungs and assessment of airway epithelial barrier function in ovalbumin-sensitized control and pre
192 a, IL-22, or IL-17A, resulted in compromised barrier function in parallel with increased p-Y280.
193 r immune-mediated therapies, especially when barrier function in the gut is compromised to trigger ab
195 vealed that cellular assembly and epithelial barrier function in the proliferative phase and inflamma
196 iew focuses on the role of airway epithelial barrier function in the susceptibility to develop asthma
199 cial for epithelial adhesion, integrity, and barrier functions in a wide variety of tissues and organ
200 were in or near genes relevant to epithelial barrier function, including CDHR3 and CDH26, and in othe
201 implicated in multiple aspects of epithelial barrier function, including regulation of epithelial cel
204 genetic impairment in intestinal epithelial barrier function, junctional adhesion molecule A knockou
205 sion is an important mechanism in intestinal barrier function maintenance and in the prevention of co
206 data suggest that a compromise in intestinal barrier function may contribute significantly to the pat
207 onged approach, not only restoring cutaneous barrier function, microbial flora, and immune homeostasi
208 endothelial cell S1P(1) supports blood-brain barrier function, microvascular patency, and the rerouti
211 the aforementioned maintenance of epithelial barrier function, nutrient absorption, and immune regula
214 attribute of the lymphatic vasculature, the barrier function of collecting lymphatic vessels is also
217 changes in DNA methylation and impaired the barrier function of cultured primary gingival epithelial
218 king the physiological or pathophysiological barrier function of endothelial and epithelial cells is
219 rative colitis secreted IL22, which promoted barrier function of human intestinal epithelial cells.
225 ricytes that recapitulates the high level of barrier function of the in vivo human BBB for at least o
226 ling or depletion of the microbiome restores barrier function of the intestinal epithelium, leading t
227 also found that IGF2BP1 removal compromises barrier function of the intestinal epithelium, resulting
229 s characterized by the loss of stem cell and barrier function of the limbus leading to progressive pa
231 healing non-destructively by focusing on the barrier function of the RHE as a main feature of intact
232 piratory cells that will maintain epithelial barrier function once the capacity to regenerate OE cell
233 erage, reduced vascular perfusion, defective barrier function, overlying epithelial abnormalities, an
234 ed microgravity alters intestinal epithelial barrier function (permeability), and susceptibility to b
236 the polarized cell architecture, intestinal barrier function, presence of specialized cell subpopula
238 etal muscle fibers with compromised membrane barrier function, providing a continuous source of autoa
239 pic culture leads to enhanced development of barrier function, reflecting increased expression of str
240 ons, including key modulators of endothelial barrier function, regulators of gene transcription, and
241 ll-cell junctions, apico-basal polarity, and barrier function remain intact, cells elongate and align
246 pesviruses benefit from this partial loss-of-barrier function, resulting in increased infection of th
247 endothelial quiescence and maintenance of EC barrier function results in disturbed angiopoietin 1 Tie
248 ride channel Ano1/Tmem16a compromises airway barrier function, results in early signs of inflammation
249 d not previously been linked with effects on barrier function, single-cell RNA sequencing uncovered m
250 triclosan exposure include those involved in barrier function, small molecule uptake, and integrity o
251 -1beta lies upstream of disrupted intestinal barrier function, subsequent IgA vasculitis development,
252 downregulation of molecules involved in the barrier function, such as filaggrin, occludin, and claud
253 ch IDL improves skin hydration and epidermal barrier function, supporting IDL as an effective interve
254 Vs (takes 1-7 d); and how to assess vascular barrier function (takes 1 d) and perform immunofluoresce
255 3s) are mediators of intestinal immunity and barrier function that possess the capacity to acquire ty
256 The interplay between intestinal epithelial barrier function, the intestinal microbiota, and cytokin
258 spinal fluid-like secretion and recapitulate barrier functions, thereby inspiring new advances for ta
259 receptor NOTCH1 directly regulates vascular barrier function through a non-canonical, transcription-
260 negatively affects the endothelial cell (EC) barrier function through a novel regulatory mechanism.
263 erse vascular damage and restore endothelial barrier function through regeneration of a functional en
264 factor negatively regulates endothelial cell barrier function through suppression of glucose-6-phosph
267 demonstrate that UroA and UAS03 exert their barrier functions through activation of aryl hydrocarbon
268 omotes (but recombinant protein disrupts) EC barrier function, thus affecting the barrier-forming pro
273 t transcriptomic signature enriched for skin barrier function, tryptophan metabolism and immune activ
275 idermal lipid metabolism and adult epidermal barrier function, ultimately resulting in chronic skin b
276 fatty acids (FAs) thought to be critical for barrier function, unbound omega-O-acylceramide and bound
277 r TLR2 or TLR3 stimulation alters epithelial barrier function using an in vitro model of human epithe
278 ed on endothelial cells regulate blood-brain barrier function via myosin light chain phosphorylation
279 regulate islet vascularization and vascular barrier function via the VEGF-A/VEGFR2 signaling pathway
283 ion, suggesting that the effect of miR-24 on barrier function was due to an effect on cell-cell junct
287 ct of MC(TC)s on in vitro tube formation and barrier function was studied using primary fetal human p
290 ver the supplementation period, and improved barrier function when combined with micronutrients.
291 e a damage control mechanism that reinstates barrier function when tight junctions become locally com
292 been associated with an impaired epithelial barrier function, which allows allergens, pollutants, or
293 cerebral blood flow and impaired blood-brain barrier function, which are leading contributors to age-
294 N-induced intestinal cell injury and enhance barrier function, which is associated with inhibition of
295 e-IL-1beta-may transiently impair epithelial barrier function, while IL-1beta and IL-17 increase muci
296 say to dynamically measure local endothelial barrier function with a lateral resolution of ~15 mum an
297 other advances in understanding endothelial barrier function with the goal of identifying and reconc
298 biomarker profiles of skin inflammation and barrier function, with associated improvements in clinic
300 ollicle cycling and, in so doing, to promote barrier function, wound healing and hair growth, while l